Category: Heel Pharmacological Index

Herpes zoster-Nosode-Injeel
D 12, D 30, D 200 0.367 ml each.
Herpes zoster-Nosode-Injeel forte
D 8, D 12, D 30, D 200 0.275 ml each.

In fresh herpes zoster, the simple Injeel can be applied advantageously, while at the full development of the herpes zoster vesicles, i.e. about 10-14 days after the start of the illness, Herpes zoster-Nosode-Injeel forte should first be administered and then, in the further course of the treatment, a transfer should be made to Herpes zoster-Nosode-Injeel. Further, for postherpetic neuralgia, frequently very resistant to therapy, as well as for other diseases similar to herpes or zoster.

Cerebrum frontalis suis-Injeel and forte
(anterior section of the brain)

Disturbances of intelligence and reasoning faculty, disturbances of development in children.

Insulin-Injeel
D 12, D 30, D 200 0.367 ml each.
Insulin-Injeel forte S
D 8, D 12, D 30, D 200 0.275 ml each.

To be used experimentally, in the homoeopathic reversal effect, for hyperinsulinism (insuloma as well as functional) with hypoglycemic conditions as well as damage through/after insulin, e.g. insulin lipodystrophy. Insulin-Injeel and forte is not suitable for substitution therapy in diabetes mellitus.

Magnesium phosphoricum-Injeel
D 12, D 30, D 200 0.367 ml each.
Magnesium phosphoricum-Injeel forte
D 6, D 12, D 30, D 200 0.275 ml each.

Tendency to cramps; neuralgia, disorders of dentition (children), dysmenorrhoea.

Bursa pastoris-Injeel
D 12, D 30, D 200 0.367 ml each.

Haemorrhages, haematuria, metrorrhagia, menorrhagia.

Argentum nitricum-Injeel
D 12, D 30, D 200 0.367 ml each.
Argentum nitricum-Injeel forte
D 6, D 12, D 30, D 200 0.275 ml each.

Melancholia, loss of memory, agoraphobia, splinter pains; headache improved by firm bandaging; pharyngitis, laryngitis, hoarseness, conjunctivitis, gastritis, ulcus ventriculi, gastrorrhagia, enuresis, strong desire for sweetmeats.

Streptomycin-Injeel
D 12, D 30, D 200 0.367 ml each.
Streptomycin-Injeel forte
D 6, D 12, D 30, D 200 0.275 ml each.

Streptomycin belongs to the group of aminoglycoside antibiotics. The Indications include, in addition to Gram negative cocci and bacteria, above all the tubercle bacilli. Contraindications for all aminoglycoside antibiotics are serious cardiogenic and nephrogenic secretory disorders. As side effects of this group of antibiotics, the following should be mentioned: renal damage, neuromuscular blockages, paresthesia, muscular pains. In addition to the nephrotoxic properties of streptomycin, allergic reactions are known, i.e. in the form of urticarial eczema and generalized exfoliative dermatitis. Also liver damage and granulorytopenia after the administration of streptomycin are regarded as allergic. Above all, however, streptomycin is neurotoxic, with special affinity to the eighth cerebral nerve. In this connection streptomycin has a special affinity to the vestibular function (symptoms of vertigo, disturbances of equilibrium and gait), while dihydrostreptomycin has a special affinity to the cochlear function (hearing impairment extending to dysacousis and deafness). Cochlear damage, contrary to vestibular disturbance, is practically always irreversible.

Indications

The above-mentioned clinical pictures, in particular symptoms of vertigo, disturbances of equilibrium and gait, but also hearing impairment such as tinnitus aurium, dysacousis and deafness, as also streptomycin, and not only dihydrostreptomycin, can bring about acoustical and cochlear disturbances.

Ornithogalum umbellatum-Injeel
D 10, D 30, D 200 0.367 ml each.

Inflammatory and vesicular skin affections, nausea and emesis, e.g. in ulcus ventriculi et duodeni.

Antimonium suifuratum aurantiacum-Injeel
D 10, D 30, D 200 0.367 ml each.
Antimonium sulfuratum aurantiacum-Injeel forte
D 6, D 10, D 30, D 200 0.275 ml each.

Chronic asthma, bronchial catarrh.

Carcinoma bronchium-Injeel
D 10, D 30, D 200 0.367 ml each.
Carcinoma bronchium-Injeel forte
D 6, D 10, D 30, D 200 0.275 ml each.

For auxiliary/additional therapy in bronchial carcinoma (particularly post-operative); chronic bronchitis and smoker’s catarrh (in this connection bronchial carcinoma should not be overlooked).